In particular, the expression of IL-6 by CD19/B cells was significantly different after stimulation with HERV-K env 109–126 peptide in ALS patients in comparison to HCs, suggesting that this peptide is likely responsible for the B-cell activation, considered the autocrine activity of this cytokine. Here, CD19 is linked to amyotrophic lateral sclerosis.